My understanding is it’s not as necessary at safety stage, of course the P2 needs to be <0.05 for the FDA to take any sort of serious looks at approvals.
Ann: Positive Phase 1 MEND Study Top-Line Results, page-150
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
17.5¢ |
Change
0.005(2.94%) |
Mkt cap ! $82.69M | |||
| Open | High | Low | Value | Volume |
| 17.5¢ | 17.5¢ | 17.0¢ | $52.47K | 300.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 567354 | 17.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 18.0¢ | 205056 | 4 |
View Market Depth
| Last trade - 14.27pm 10/09/2024 (20 minute delay) ? |
| PAA (ASX) Chart |